MMSI — Merit Medical Systems Cashflow Statement
0.000.00%
- $5.59bn
- $5.93bn
- $1.36bn
- 92
- 26
- 80
- 73
Annual cashflow statement for Merit Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 45.4 | 25.5 | 33.9 | 32.1 | 37.5 |
Unusual Items | |||||
Purchased R&D | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 34.2 | -17.8 | -71.4 | -70 | -36.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 165 | 147 | 114 | 145 | 221 |
Capital Expenditures | -49.3 | -30.8 | -45 | -36.7 | -38 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -9.38 | -6.39 | -12.4 | -139 | -331 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -58.7 | -37.2 | -57.4 | -175 | -369 |
Financing Cash Flow Items | -14 | -11.2 | -35.4 | -75.9 | -1.85 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -95.7 | -98.4 | -60.3 | 559 | -60 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 12.6 | 10.8 | -7.19 | 529 | -210 |